Table of Contents Author Guidelines Submit a Manuscript
Oxidative Medicine and Cellular Longevity
Volume 2013, Article ID 385214, 11 pages
http://dx.doi.org/10.1155/2013/385214
Research Article

Proteomic Analysis of Plasma-Purified VLDL, LDL, and HDL Fractions from Atherosclerotic Patients Undergoing Carotid Endarterectomy: Identification of Serum Amyloid A as a Potential Marker

1Dipartimento di Scienze Biomediche, University of Sassari, Via Muroni 25, 07100 Sassari, Italy
2Servizio di Chirurgia Vascolare, Clinica Chirurgica Generale, University of Sassari, Viale S. Pietro 43/B, 07100 Sassari, Italy
3Centro Cardiologico “F. Monzino,” IRCCS, University of Milan, Via Carlo Parea 4, 20138 Milan, Italy
4Nurex S.r.l., Via Predda Niedda Strada 3, 07100 Sassari, Italy
5Dipartimento di Genetica, Biologia, Biochimica, University of Turin, Via Santena 19, 10126 Turin, Italy

Received 11 October 2013; Revised 18 November 2013; Accepted 20 November 2013

Academic Editor: Joseph Fomusi Ndisang

Copyright © 2013 Antonio J. Lepedda et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. E. Lutgens, R.-J. van Suylen, B. C. Faber et al., “Atherosclerotic plaque rupture: local or systemic process?” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 23, no. 12, pp. 2123–2130, 2003. View at Publisher · View at Google Scholar · View at Scopus
  2. P. Libby, “Inflammation in atherosclerosis,” Nature, vol. 420, no. 6917, pp. 868–874, 2002. View at Publisher · View at Google Scholar · View at Scopus
  3. K. J. Williams and I. Tabas, “The response-to-retention hypothesis of early atherogenesis,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 15, no. 5, pp. 551–562, 1995. View at Google Scholar · View at Scopus
  4. K. Skålén, M. Gustafsson, E. Knutsen Rydberg et al., “Subendothelial retention of atherogenic lipoproteins in early atherosclerosis,” Nature, vol. 417, no. 6890, pp. 750–754, 2002. View at Publisher · View at Google Scholar · View at Scopus
  5. A. Jonas and M. C. Phillips, “Lipoprotein structure,” in Biochemistry of Lipids, Lipoprotein and Membranes, D. E. Vance and J. E. Vance, Eds., pp. 485–506, Elsevier, 5th edition, 2008. View at Google Scholar
  6. V. M. Bolanos-Garcia and R. N. Miguel, “On the structure and function of apolipoproteins: more than a family of lipid-binding proteins,” Progress in Biophysics and Molecular Biology, vol. 83, no. 1, pp. 47–68, 2003. View at Publisher · View at Google Scholar · View at Scopus
  7. G. Walldius, I. Jungner, I. Holme, A. H. Aastveit, W. Kolar, and E. Steiner, “High apolipoprotein B, low apolipoprotein A-I, and improvement in the prediction of fatal myocardial infarction (AMORIS study): a prospective study,” The Lancet, vol. 358, no. 9298, pp. 2026–2033, 2001. View at Publisher · View at Google Scholar · View at Scopus
  8. A. J. Lepedda, E. Zinellu, and M. Formato, “Overview of current proteomic approaches for discovery of vascular biomarkers of atherosclerosis,” in Proteomics—Human Diseases and Protein Functions, T.-K. Man and J. R. Flores, Eds., pp. 3–32, InTech, 2012. View at Google Scholar
  9. A. von Zychlinski, T. Kleffmann, M. J. A. Williams, and S. P. McCormick, “Proteomics of Lipoprotein(a) identifies a protein complement associated with response to wounding,” Journal of Proteomics, vol. 74, no. 12, pp. 2881–2891, 2011. View at Publisher · View at Google Scholar · View at Scopus
  10. T. Vaisar, S. Pennathur, P. S. Green et al., “Shotgun proteomics implicates protease inhibition and complement activation in the antiinflammatory properties of HDL,” Journal of Clinical Investigation, vol. 117, no. 3, pp. 746–756, 2007. View at Publisher · View at Google Scholar · View at Scopus
  11. P. S. Green, T. Vaisar, S. Pennathur et al., “Combined statin and niacin therapy remodels the high-density lipoprotein proteome,” Circulation, vol. 118, no. 12, pp. 1259–1267, 2008. View at Publisher · View at Google Scholar · View at Scopus
  12. T. Vaisar, P. Mayer, E. Nilsson, X.-Q. Zhao, R. Knopp, and B. J. Prazen, “HDL in humans with cardiovascular disease exhibits a proteomic signature,” Clinica Chimica Acta, vol. 411, no. 13-14, pp. 972–979, 2010. View at Publisher · View at Google Scholar · View at Scopus
  13. K. Alwaili, D. Bailey, Z. Awan et al., “The HDL proteome in acute coronary syndromes shifts to an inflammatory profile,” Biochimica et Biophysica Acta, vol. 1821, no. 3, pp. 405–415, 2012. View at Publisher · View at Google Scholar · View at Scopus
  14. J. Cubedo, T. Padró, R. Alonso, J. Cinca, P. Mata, and L. Badimon, “Differential proteomic distribution of TTR (pre-albumin) forms in serum and HDL of patients with high cardiovascular risk,” Atherosclerosis, vol. 222, no. 1, pp. 263–269, 2012. View at Publisher · View at Google Scholar · View at Scopus
  15. M. Heller, E. Schlappritzi, D. Stalder, J.-M. Nuoffer, and A. Haeberli, “Compositional protein analysis of high density lipoproteins in hypercholesterolemia by shotgun LC-MS/MS and probabilistic peptide scoring,” Molecular and Cellular Proteomics, vol. 6, no. 6, pp. 1059–1072, 2007. View at Publisher · View at Google Scholar · View at Scopus
  16. M. T. Mazura, H. L. Cardasis, D. S. Spellman, A. Liaw, N. A. Yates, and R. C. Hendrickson, “Quantitative analysis of intact apolipoproteins in human HDL by top-down differential mass spectrometry,” Proceedings of the National Academy of Sciences of the United States of America, vol. 107, no. 17, pp. 7728–7733, 2010. View at Publisher · View at Google Scholar · View at Scopus
  17. J. H. M. Levels, P. Geurts, H. Karlsson et al., “High-density lipoprotein proteome dynamics in human endotoxemia,” Proteome Science, vol. 9, article 34, 2011. View at Publisher · View at Google Scholar · View at Scopus
  18. P. Davidsson, J. Hulthe, B. Fagerberg et al., “A proteomic study of the apolipoproteins in LDL subclasses in patients with the metabolic syndrome and type 2 diabetes,” Journal of Lipid Research, vol. 46, no. 9, pp. 1999–2006, 2005. View at Publisher · View at Google Scholar · View at Scopus
  19. P. V. Bondarenko, S. L. Cockrill, L. K. Watkins, I. D. Cruzado, and R. D. Macfarlane, “Mass spectral study of polymorphism of the apolipoproteins of very low density lipoprotein,” Journal of Lipid Research, vol. 40, no. 3, pp. 543–555, 1999. View at Google Scholar · View at Scopus
  20. A. J. Lepedda, A. Cigliano, G. M. Cherchi et al., “A proteomic approach to differentiate histologically classified stable and unstable plaques from human carotid arteries,” Atherosclerosis, vol. 203, no. 1, pp. 112–118, 2009. View at Publisher · View at Google Scholar · View at Scopus
  21. A. J. Lepedda, A. Zinellu, G. Nieddu et al., “Protein sulfhydryl group oxidation and mixed-disulfide modifications in stable and unstable human carotid plaques,” Oxidative Medicine and Cellular Longevity, vol. 2013, Article ID 403973, 8 pages, 2013. View at Publisher · View at Google Scholar
  22. J. Himber, E. Buhler, D. Moll, and U. K. Moser, “Low density lipoprotein for oxidation and metabolic studies. Isolation from small volumes of plasma using a tabletop ultracentrifuge,” International Journal for Vitamin and Nutrition Research, vol. 65, no. 2, pp. 137–142, 1995. View at Google Scholar · View at Scopus
  23. I. F. W. McDowell, J. McEneny, and E. R. Trimble, “A rapid method for measurement of the susceptibility to oxidation of low-density lipoprotein,” Annals of Clinical Biochemistry, vol. 32, no. 2, pp. 167–174, 1995. View at Google Scholar · View at Scopus
  24. R. Mastro and M. Hall, “Protein delipidation and precipitation by tri-n-butylphosphate, acetone, and methanol treatment for isoelectric focusing and two-dimensional gel electrophoresis,” Analytical Biochemistry, vol. 273, no. 2, pp. 313–315, 1999. View at Publisher · View at Google Scholar · View at Scopus
  25. V. L. King, J. Thompson, and L. R. Tannock, “Serum amyloid A in atherosclerosis,” Current Opinion in Lipidology, vol. 22, no. 4, pp. 302–307, 2011. View at Publisher · View at Google Scholar · View at Scopus
  26. S. P. Tam, A. Flexman, J. Hulme, and R. Kisilevsky, “Promoting export of macrophage cholesterol: the physiological role of a major acute-phase protein, serum amyloid A 2.1,” Journal of Lipid Research, vol. 43, no. 9, pp. 1410–1420, 2002. View at Publisher · View at Google Scholar · View at Scopus
  27. J. A. Stonik, A. T. Remaley, S. J. Demosky, E. B. Neufeld, A. Bocharov, and H. B. Brewer, “Serum Amyloid a promotes ABCA1-dependent and ABCA1-independent lipid efflux from cells,” Biochemical and Biophysical Research Communications, vol. 321, no. 4, pp. 936–941, 2004. View at Publisher · View at Google Scholar · View at Scopus
  28. S. P. Tam, J. B. Ancsin, R. Tan, and R. Kisilevsky, “Peptides derived from serum amyloid A prevent, and reverse, aortic lipid lesions in apoE−/− mice,” Journal of Lipid Research, vol. 46, no. 10, pp. 2091–2101, 2005. View at Publisher · View at Google Scholar · View at Scopus
  29. D. R. van der Westhuyzen, L. Cai, M. C. DeBeer, and F. C. DeBeer, “Serum amyloid A promotes cholesterol efflux mediated by scavenger receptor B-I,” Journal of Biological Chemistry, vol. 280, no. 43, pp. 35890–35895, 2005. View at Publisher · View at Google Scholar · View at Scopus
  30. R. Kisilevsky, S. P. Tam, and J. B. Ancsin, “The anti-atherogenic potential of serum amyloid A peptides,” Current Opinion in Investigational Drugs, vol. 9, no. 3, pp. 265–273, 2008. View at Google Scholar · View at Scopus
  31. R. Badolato, J. M. Wang, W. J. Murphy et al., “Serum amyloid A is a chemoattractant: induction of migration, adhesion, and tissue infiltration of monocytes and polymorphonuclear leukocytes,” Journal of Experimental Medicine, vol. 180, no. 1, pp. 203–209, 1994. View at Publisher · View at Google Scholar · View at Scopus
  32. Y. L. Ha, D. K. Sang, W. S. Jae et al., “Serum amyloid A induces CCL2 production via formyl peptide receptor-like 1-mediated signaling in human monocytes,” Journal of Immunology, vol. 181, no. 6, pp. 4332–4339, 2008. View at Google Scholar · View at Scopus
  33. Z. Dong, T. Wu, W. Qin et al., “Serum amyloid a directly accelerates the progression of atherosclerosis in apolipoprotein E-deficient mice,” Molecular Medicine, vol. 17, no. 11, pp. 1357–1364, 2011. View at Publisher · View at Google Scholar · View at Scopus
  34. H. Y. Lee, S. D. Kim, S. H. Baek et al., “Serum amyloid A stimulates macrophage foam cell formation via lectin-like oxidized low-density lipoprotein receptor 1 upregulation,” Biochemical and Biophysical Research Communications, vol. 433, no. 1, pp. 18–23, 2013. View at Publisher · View at Google Scholar
  35. C. J. Furlaneto and A. Campa, “A novel function of serum amyloid A: a potent stimulus for the release of tumor necrosis factor-α, interleukin-1β, and interleukin-8 by human blood neutrophil,” Biochemical and Biophysical Research Communications, vol. 268, no. 2, pp. 405–408, 2000. View at Publisher · View at Google Scholar · View at Scopus
  36. C. Song, K. Hsu, E. Yamen et al., “Serum amyloid A induction of cytokines in monocytes/macrophages and lymphocytes,” Atherosclerosis, vol. 207, no. 2, pp. 374–383, 2009. View at Publisher · View at Google Scholar · View at Scopus
  37. S. Hua, C. Song, C. L. Geczy, S. B. Freedman, and P. K. Witting, “A role for acute-phase serum amyloid A and high-density lipoprotein in oxidative stress, endothelial dysfunction and atherosclerosis,” Redox Report, vol. 14, no. 5, pp. 187–196, 2009. View at Publisher · View at Google Scholar · View at Scopus
  38. P. K. Witting, C. Song, K. Hsu et al., “The acute-phase protein serum amyloid A induces endothelial dysfunction that is inhibited by high-density lipoprotein,” Free Radical Biology and Medicine, vol. 51, no. 7, pp. 1390–1398, 2011. View at Publisher · View at Google Scholar · View at Scopus
  39. C. Song, Y. Shen, E. Yamen et al., “Serum amyloid A may potentiate prothrombotic and proinflammatory events in acute coronary syndromes,” Atherosclerosis, vol. 202, no. 2, pp. 596–604, 2009. View at Publisher · View at Google Scholar · View at Scopus
  40. P. G. Wilson, J. C. Thompson, N. R. Webb, F. C. DeBeer, V. L. King, and L. R. Tannock, “Serum amyloid A, but not C-reactive protein, stimulates vascular proteoglycan synthesis in a pro-atherogenic manner,” American Journal of Pathology, vol. 173, no. 6, pp. 1902–1910, 2008. View at Publisher · View at Google Scholar · View at Scopus
  41. J. B. Ancsin and R. Kisilevsky, “Serum amyloid A peptide interactions with glycosaminoglycans. Evaluation by affinity chromatography,” Methods in Molecular Biology, vol. 171, pp. 449–456, 2001. View at Google Scholar · View at Scopus
  42. K. D. O'Brien, T. O. McDonald, V. Kunjathoor et al., “Serum amyloid A and lipoprotein retention in murine models of atherosclerosis,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 25, no. 4, pp. 785–790, 2005. View at Publisher · View at Google Scholar · View at Scopus
  43. T. Yamada, T. Kakihara, T. Kamishima, T. Fukuda, and T. Kawai, “Both acute phase and constitutive serum amyloid A are present in atherosclerotic lesions,” Pathology International, vol. 46, no. 10, pp. 797–800, 1996. View at Google Scholar · View at Scopus
  44. R. L. Meek, S. Urieli-Shoval, and E. P. Benditt, “Expression of apolipoprotein serum amyloid A mRNA in human atherosclerotic lesions and cultured vascular cells: implications for serum amyloid A function,” Proceedings of the National Academy of Sciences of the United States of America, vol. 91, no. 8, pp. 3186–3190, 1994. View at Google Scholar · View at Scopus
  45. G. Liuzzo, L. M. Biasucci, J. R. Gallimore et al., “The prognostic value of C-reactive protein and serum amyloid A protein in severe unstable angina,” The New England Journal of Medicine, vol. 331, no. 7, pp. 417–424, 1994. View at Publisher · View at Google Scholar · View at Scopus
  46. A. I. Fyfe, L. S. Rothenberg, F. C. DeBeer, R. M. Cantor, J. I. Rotter, and A. J. Lusis, “Association between serum amyloid A proteins and coronary artery disease: evidence from two distinct arteriosclerotic processes,” Circulation, vol. 96, no. 9, pp. 2914–2919, 1997. View at Google Scholar · View at Scopus
  47. M. Erren, H. Reinecke, R. Junker et al., “Systemic inflammatory parameters in patients with atherosclerosis of the coronary and peripheral arteries,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 19, no. 10, pp. 2355–2363, 1999. View at Google Scholar · View at Scopus
  48. N. Rifai, R. Joubran, H. Yu, M. Asmi, and M. Jouma, “Inflammatory markers in men with angiographically documented coronary heart disease,” Clinical Chemistry, vol. 45, no. 11, pp. 1967–1973, 1999. View at Google Scholar · View at Scopus
  49. P. Jousilahti, V. Salomaa, V. Rasi, E. Vahtera, and T. Palosuo, “The association of c-reactive protein, serum amyloid a and fibrinogen with prevalent coronary heart disease—baseline findings of the PAIS project,” Atherosclerosis, vol. 156, no. 2, pp. 451–456, 2001. View at Publisher · View at Google Scholar · View at Scopus
  50. J. R. Delanghe, M. R. Langlois, D. de Bacquer et al., “Discriminative value of serum amyloid A and other acute-phase proteins for coronary heart disease,” Atherosclerosis, vol. 160, no. 2, pp. 471–476, 2002. View at Publisher · View at Google Scholar · View at Scopus
  51. K. Ogasawara, S. Mashiba, Y. Wada et al., “A serum amyloid A and LDL complex as a new prognostic marker in stable coronary artery disease,” Atherosclerosis, vol. 174, no. 2, pp. 349–356, 2004. View at Publisher · View at Google Scholar · View at Scopus
  52. B. D. Johnson, K. E. Kip, O. C. Marroquin et al., “Serum amyloid A as a predictor of coronary artery disease and cardiovascular outcome in women: The National Heart, Lung, and Blood Institute-Sponsored Women's Ischemia Syndrome Evaluation (WISE),” Circulation, vol. 109, no. 6, pp. 726–732, 2004. View at Publisher · View at Google Scholar · View at Scopus
  53. K. W. J. Lee, J. S. Hill, K. R. Walley, and J. J. Frohlich, “Relative value of multiple plasma biomarkers as risk factors for coronary artery disease and death in an angiography cohort,” Canadian Medical Association Journal, vol. 174, no. 4, pp. 461–466, 2006. View at Publisher · View at Google Scholar · View at Scopus